Contract 75H71222A00008
Biomerieux Inc · Department Of Health And Human Services · September 28, 2022
Biomerieux Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on September 28, 2022 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 31, 2026. If all options are exercised, the contract could reach $750,000.
Contract details
- PIID
- 75H71222A00008
- Award type
- —
- Pricing
- Firm Fixed Price
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- September 28, 2022
- Latest action
- March 31, 2026
Description
LABORATORY SUPPLIES, PAO
Modification timeline
-
March 31, 2026Mod P00005$0
-
February 3, 2026Mod P00004$0
-
May 1, 2024Mod P00003$0
-
April 29, 2024Mod P00002$0
-
July 12, 2023Mod P00001$0
-
September 28, 2022Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
| Remel Inc. | Department Of Health And Human Services | March 30, 2026 | $74.6K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71222A00008?
Contract 75H71222A00008 is a federal contract awarded to Biomerieux Inc by Department Of Health And Human Services on September 28, 2022 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 75H71222A00008?
Biomerieux Inc won contract 75H71222A00008 from Department Of Health And Human Services.
How much is contract 75H71222A00008 worth?
Contract 75H71222A00008 has obligated $0 to date but carries a potential ceiling of $750,000 if fully funded and all options are exercised.